Advanced Contamination Control: Automation, Assays, Process Efficiency

Simplify Your Downstream Calculations With Bioprocessing Downstream Calculators

Reimagine Sustainability In Bioprocessing

Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective

Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

Rapid Process Development And Technical Support For AAV Scaleup

2025 CGT Regulatory Outlook

Unlocking The Future Of Allogeneic Cell Therapy For Oncology

2024 Regulatory Outlook With FDA's Drs. Peter Marks And Nicole Verdun

mRNA For Cancer Immunotherapy: 2024 Outlook

Stability To Scalability: The Future Of Viral Vector Therapies

Driving Down COGS: Automation's Role In Cell Therapy Manufacturing

Tackling Cell And Gene Therapies' Top 3 Regulatory Impediments

2025 CGT Regulatory Outlook | Audience Q&A

Navigating Global Regulations, Equity Challenges, And The Future Of Patient Access

How The FDA's 2024 Draft Guidances Will Influence CGT Regulation In 2025

How The New Administration Could Shape FDA Oversight, Compliance, And Guidance In 2025

How The FDA Strengthens Industry Collaboration

Key Regulatory Challenges, Innovations, And Opportunities For CGT In 2025

Congruence And Divergence In Global Regulatory Approvals

Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A

Autoimmune Disease Research's Impact On The Development Of Cell Therapies For Oncology

Defining The CMC / Clinical Relationship For Allogeneic Cell Therapies

Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology

Best Practices For Effective Donor Management

Maximizing Media Strategies: Expert Insights On Boosting Performance

Planning for Success: Supply Resiliency Strategies for Bench to Production

Innovative Strategies For Residual DNA And Viral Titre Quantitation

The Role Of Peptones In Boosting Quality And Yield

Accelerate Process Development With HTS Chromatography Tools

Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency

Successful Microbial Testing And Identification

Upstream To Downstream: A Comprehensive Approach To AAV Production

Accelerating mAb Process Development In The Growing Therapeutics Market

Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

Sustainable Manufacturing Through Efficient BioProduction Unit Operations

The Way Forward: Supply Chain Solutions

Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways

Ensure Consistency Across Batches With A Powerful Tool

Thermo Fisher Scientific Large Volume Liquid Expansion

Regulatory Compliance And Viral Vectors

Cell And Gene Therapy Innovations

An Active Release Mechanism For Magnetic Separation And Cell Isolation

Planning for Success: Supply Resiliency Strategies for Bench to Production

Innovative Strategies For Residual DNA And Viral Titre Quantitation

Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing

Autoimmune Disease Research's Impact On The Development Of Cell Therapies For Oncology

Accelerate Process Development With HTS Chromatography Tools

Supply Chain And Operational Challenges Facing mRNA

Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways

How The FDA's 2024 Draft Guidances Will Influence CGT Regulation In 2025

Cell And Gene Therapy Innovations

Challenge #1: The Changing Regulatory Landscape

ResDNASEQ Workflow Solution

Planning for Success: Supply Resiliency Strategies for Bench to Production

Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing

2024 Regulatory Outlook With Dr. Peter Marks And Dr. Nicole Verdun | Audience Q&A

An All-In-One Solution For Residual DNA Quantitation

Successful Microbial Testing And Identification

Dr. Peter Marks on the Adoption of Novel Precision Analytics

How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks

Ensure Consistency Across Batches With A Powerful Tool

Regulatory Compliance And Viral Vectors

Cell And Gene Therapy Innovations

An Active Release Mechanism For Magnetic Separation And Cell Isolation

Planning for Success: Supply Resiliency Strategies for Bench to Production

Supply Chain And Operational Challenges Facing mRNA

Driving Down COGS Audience Q&A

Upstream To Downstream: A Comprehensive Approach To AAV Production

Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

Market Demand For AAV Vectors

How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks

The Way Forward: Supply Chain Solutions

Regulatory Compliance And Viral Vectors

Cell And Gene Therapy Innovations

ResDNASEQ Workflow Solution

Innovative Strategies For Residual DNA And Viral Titre Quantitation

An All-In-One Solution For Residual DNA Quantitation

Successful Microbial Testing And Identification

Market Demand For AAV Vectors

Maximize Quality Assurance Through Rapid Sterility Testing

Innovative Contamination Control: Enabling Integrity And Efficiency

Digital Solutions For Accelerated Innovation

Rapid Process Development And Technical Support For AAV Scaleup

Overcoming Capacity Constraints

Ensure Consistency Across Batches With A Powerful Tool

Cell And Gene Therapy Innovations

An Active Release Mechanism For Magnetic Separation And Cell Isolation

Planning for Success: Supply Resiliency Strategies for Bench to Production

Driving Down COGS Audience Q&A

The Way Forward: Supply Chain Solutions

Safety And Efficiency Of Source Material Collection

Bioprocessing Equipment And Automation Product Portfolio Overview

Auto, Allo, And AI

Mitigating Risk In Process Automation

Innovative Contamination Control: Enabling Integrity And Efficiency

Thermo Fisher Scientific Customer Experience Center Overview